Intraperitoneal Injection of Neonatal Mice.

Adeno-associated virus (AAV) Gene therapy I.P. administration Lentivirus (LV) Mouse pup Neonate Systemic delivery Tamoxifen

Journal

Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102

Informations de publication

Date de publication:
20 Sep 2023
Historique:
received: 11 05 2023
revised: 27 07 2023
accepted: 27 07 2023
medline: 27 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

Administration of substances into neonatal mice is required for early treatment with pre-clinical therapeutics, delivery of recombination-inducing substances, and dosing with viruses or toxins, amongst other things. Several injection routes into mouse pups are possible, including intravenous and intracerebroventricular, each with their own advantages and limitations. Here, we describe a simple and rapid protocol for the intraperitoneal injection of neonatal mice for systemic dosing. By detaching a 30-gauge needle from its plastic hub and inserting it into polyethylene tubing attached to a Hamilton syringe, small volumes (1-10 μL) can be accurately injected into the peritoneal cavity of pups aged 1-5 days old. The procedure can be completed within a few minutes, is generally safe and well tolerated by both pups and parents, and can be used in combination with alternative administration routes. Key features • This protocol provides a simple description to rapidly and efficiently inject mouse pups aged 1-5 days for systemic dosing. • Allows treatment of neonatal mice with substances such as viruses and compounds for research across disciplines.

Identifiants

pubmed: 37753468
doi: 10.21769/BioProtoc.4826
pii: e4826
pmc: PMC10518777
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e4826

Informations de copyright

©Copyright : © 2023 The Authors; This is an open access article under the CC BY-NC license.

Déclaration de conflit d'intérêts

Competing interestsThe authors have no competing interest to declare.

Références

JCI Insight. 2023 May 8;8(9):
pubmed: 36928301
Pediatr Res. 2007 Jun;61(6):671-5
pubmed: 17426655
Nat Protoc. 2010 Sep;5(9):1518-34
pubmed: 20725067
Clin Ther. 2014 Mar 1;36(3):340-56.e5
pubmed: 24636820
J Am Assoc Lab Anim Sci. 2011 Sep;50(5):600-13
pubmed: 22330705
J Virol. 2001 Dec;75(24):12382-92
pubmed: 11711628
Nature. 2011 Oct 05;478(7367):123-6
pubmed: 21979052
J Vis Exp. 2014 Nov 11;(93):e52037
pubmed: 25407048
J Vis Exp. 2013 Jul 06;(77):e50409
pubmed: 23851469
Lab Anim Sci. 1999 Jun;49(3):328-30
pubmed: 10403452
Hum Gene Ther. 2008 Jan;19(1):61-70
pubmed: 18052722
Brain Dev. 2015 Apr;37(4):376-86
pubmed: 25034178
J Vis Exp. 2018 Aug 2;(138):
pubmed: 30124643
J Am Assoc Lab Anim Sci. 2007 Nov;46(6):50-4
pubmed: 17994673
J Vis Exp. 2011 Oct 03;(56):
pubmed: 21988897
Lab Anim (NY). 2011 May;40(5):155-60
pubmed: 21508954
Pharm Res. 2019 Dec 23;37(1):12
pubmed: 31873819
Neuron. 2021 May 5;109(9):1497-1512.e6
pubmed: 33823138

Auteurs

Amanda M Pocratsky (AM)

Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.

James N Sleigh (JN)

Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
UK Dementia Research Institute, University College London, London, UK.

Classifications MeSH